BGM Group (NASDAQ:BGM) Shares Gap Down – Time to Sell?

by · The Markets Daily

BGM Group Ltd. (NASDAQ:BGM – Get Free Report)’s share price gapped down prior to trading on Monday . The stock had previously closed at $7.00, but opened at $6.70. BGM Group shares last traded at $6.7650, with a volume of 2,787 shares trading hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of BGM Group in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, BGM Group has a consensus rating of “Sell”.

View Our Latest Stock Report on BGM

BGM Group Stock Performance

The business’s 50-day simple moving average is $9.05 and its two-hundred day simple moving average is $9.80.

Institutional Investors Weigh In On BGM Group

Hedge funds have recently bought and sold shares of the stock. Geode Capital Management LLC acquired a new stake in BGM Group in the second quarter valued at $412,000. Mariner LLC acquired a new stake in shares of BGM Group in the 3rd quarter worth $267,000. Finally, Marshall Wace LLP acquired a new position in BGM Group during the 2nd quarter worth approximately $218,000.

About BGM Group

(Get Free Report)

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.

Recommended Stories